Previous work has demonstrated that low levels of adiponectin among youth predicted future T2D [47] and, among youth who already developed T2D, predicted glycemic failure in response to pharmacotherapies (with or without lifestyle intervention) [48]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.